references

Ali, Tariq, et al. “Incidence and outcomes in acute kidney injury: a comprehensive population-based study.” Journal of the American Society of Nephrology 18.4 (2007): 1292-1298.

Barrantes, Fidel, et al. “Acute kidney injury predicts outcomes of non-critically ill patients.” Mayo Clinic Proceedings. Vol. 84. No. 5. Elsevier, 2009.

Bellomo, Rinaldo, John A. Kellum, and Claudio Ronco. “Acute kidney injury.” The Lancet 380.9843 (2012): 756-766.

Benjamin et al. “Forecasting the future of cardiovascular disease in the United States; a policy statement from the American Heart Association.” Circulation. (2018);137:e67–e492. 

Boehringer Ingelheim press release, August 2, 2019.

Bromberg et al. Presented at American Society of Nephrology, Nov. 5-10 (2019), Washington, DC 

Brown, Jeremiah R., et al. “Duration of acute kidney injury impacts long-term survival after cardiac surgery.” The Annals of thoracic surgery 90.4 (2010): 1142-1148.

Funakoshi, Hiroshi, and Toshikazu Nakamura. “Hepatocyte growth factor: from diagnosis to clinical applications.” Clinica chimica acta 327.1-2 (2003): 1-23.

Incerti, Devin, et al. “The Lifetime Health Burden of Delayed Graft Function in Kidney Transplant Recipients in the United States.” MDM policy & practice 3.1 (2018): 2381468318781811.

Joannidis, M. I. C. H. A. E. L., et al. “Regional expression of hepatocyte growth factor/c-met in experimental renal hypertrophy and hyperplasia.” American Journal of Physiology-Renal Physiology 267.2 (1994): F231-F236.

Koulouridis, Ioannis, et al. “Hospital-acquired acute kidney injury and hospital readmission: a cohort study.” American Journal of Kidney Diseases 65.2 (2015): 275-282.

Liu, Youhua, et al. “Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.” Kidney international 55.2 (1999): 442-453.

Mannon, Roslyn B. “Delayed graft function: the AKI of kidney transplantation.” Nephron 140.2 (2018): 94-98.

Mayne & Mohan, 2020 (submission under review) 

Mayne et. Al, Amer. Society of Nephrolgy Conference, 2019

Murugan, Raghavan, and John A. Kellum. “Acute kidney injury: what’s the prognosis?.” Nature Reviews Nephrology 7.4 (2011): 209.

Narayan, Prakash, et al. “Late intervention with the small molecule BB3 mitigates postischemic kidney injury.” American Journal of Physiology-Renal Physiology 311.2 (2016): F352-F361.

National Kidney Foundation Chronic Kidney Disease Staging System  

Neary, Roisin, Chris J. Watson, and John A. Baugh. “Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis.” Fibrogenesis & tissue repair 8.1 (2015): 18.

Pavkov, Meda E., Jessica L. Harding, and Nilka R. Burrows. “Trends in hospitalizations for acute kidney injury—United States, 2000–2014.” Morbidity and Mortality Weekly Report67.10 (2018): 289.

Schnuelle, Peter, et al. “Comparison of early renal function parameters for the prediction of 5-year graft survival after kidney transplantation.” Nephrology Dialysis Transplantation22.1 (2006): 235-245.

Silver, Samuel A., and Glenn M. Chertow. “The economic consequences of acute kidney injury.” Nephron 137.4 (2017): 297-301.

Turin, Tanvir Chowdhury, et al. “Chronic kidney disease and life expectancy.” Nephrology Dialysis Transplantation 27.8 (2012): 3182-3186.

UNOS, 2019

US Presidential Executive Order July 10, 2019

US HHS press release December 18, 2019  

USRDS ADR 2018 

Wang, Ying, and Rinaldo Bellomo. “Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.” Nature Reviews Nephrology 13.11 (2017): 697.

Wynn, Thomas A. “Fibrotic disease and the T H 1/T H 2 paradigm.” Nature Reviews Immunology 4.8 (2004): 583.

Zhou, Dong, et al. “Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury.” Kidney international 84.3 (2013): 509-520.